Larry L Ressler, MD in Arcadia, OK - Emergency Medicine

Larry L Ressler, MD is a Emergency Medicine physician based in Arcadia, Oklahoma. Larry L Ressler is licensed to practice in Oklahoma (license number 17324) and his current practice location is 2325 N Post Rd, Arcadia, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (405) 396-8858.

NPI number for Larry L Ressler is 1073632865 and his current mailing address is 2325 N Post Rd, Arcadia, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1073632865.

Contact Information

	Larry L Ressler, MD
	2325 N Post Rd, Arcadia, OK 73007-7308
	(405) 396-8858
	Not Available

Physician's Profile

Full Name	Larry L Ressler
Gender	Male
Speciality	Emergency Medicine
Location	2325 N Post Rd, Arcadia, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1073632865
Provider Enumeration Date: 03/29/2007
Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for Larry L Ressler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073632865	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	17324 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Larry L Ressler is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Larry L Ressler, MD 2325 N Post Rd, Arcadia, OK 73007-7308 Ph: (405) 396-8858	Larry L Ressler, MD 2325 N Post Rd, Arcadia, OK 73007-7308 Ph: (405) 396-8858

News Archive

Honeycomb-like polymer implant helps re-build the faces of children

British and Russian surgeons are using a revolutionary honeycomb-like polymer implant to help re-build the faces of children injured in accidents or born with serious defects. The material bonds with bone without causing adverse reactions.

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.

Researchers participate in Alzheimer's Breakthrough Ride to urge Congress make the disease a national priority

This summer, more than 55 researchers participating in the Alzheimer's Breakthrough Ride are cycling relay-style across the country, collecting petition signatures asking Congress to make Alzheimer's disease a national priority. The public response to the petition has been so overwhelming that as the Alzheimer's Breakthrough Riders hit the halfway point in their 67-day route from San Francisco to Washington, D.C. on August 18, they are already more than 80% of the way to their goal of 50,000 signatures.

New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity

An analysis of race and ethnicity data from the TAILORx clinical trial was presented at the 2018 San Antonio Breast Cancer Symposium.

Nanoparticle exposure can trigger dormant viruses in lung tissue cells

Nanoparticles from combustion engines can activate viruses that are dormant in lung tissue cells. This is the result of a study by researchers of Helmholtz Zentrum München, a partner in the German Center for Lung Research, which has now been published in the journal 'Particle and Fibre Toxicology'.

Larry L Ressler, MD - Emergency Medicine in Arcadia, OK